February 19, 2022 Comments Off on New patent for Therapeuticsmd Inc drug IMVEXXY Posted in: Patent Added Annual Drug Patent Expirations for IMVEXXY Imvexxy is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post New patent for Therapeuticsmd Inc drug IMVEXXY appeared firs…
February 19, 2022 Comments Off on New patent for Biocryst drug ORLADEYO Posted in: Patent Added Annual Drug Patent Expirations for ORLADEYO Orladeyo is a drug marketed by Biocryst and is included in one NDA. There are five patents protecting this drug. This drug has forty-eight…
The post New patent for Biocryst drug ORLADEYO appeared first on Dru…
